First Page | Meta Content | |
---|---|---|
Document Date: 2012-01-05 16:38:47Open Document File Size: 307,57 KBShare Result on FacebookCityFort Worth / /CompanyBayer Pharma AG / Aerobic Gram / Novartis / Alcon Laboratories Inc. / Ames / Acinetobacter lwoffii* Haemophilus / /CountryUnited States / /Currencypence / /IndustryTermsterile ophthalmic solution / isotonic solution / viridans / topical ophthalmic solution / sterile solution / otitis media / hydrochloride ophthalmic solution / /MedicalConditionloss of consciousness / keratitis / allergic reaction / ocular hyperemia / occasionally fatal hypersensitivity / airway obstruction / morganii Neisseria gonorrhoeae Proteus mirabilis Proteus vulgaris Pseudomonas / dyspnea / ophthalmic infections / ocular pruritus / Carcinogenesis / Serious acute hypersensitivity / ophthalmological infections / conjunctival infections / anaphylaxis / rhinitis / itching / fever / superinfection / conjunctivitis / pain / urticaria / angioedema / hypersensitivity / infection / bacterial conjunctivitis / clinical infections / otitis media / cough / infections / rash / pharyngitis / /MedicalTreatmentantibiotics / alternative therapy / emergency treatment / /OrganizationDOSAGE AND ADMINISTRATION / FDA / / /Positionphysician / /ProductVIGAMOX / sodium chloride / moxifloxacin hydrochloride / /ProvinceOrStateTexas / /TechnologyPharmacokinetics / DNA synthesis / anti-infectives / /URLwww.fda.gov/medwatch / /SocialTag |